Judge advances Epic-Particle Health lawsuit

A federal judge has allowed key claims in Particle Health's antitrust lawsuit against Epic to move forward, marking the first time such allegations against the EHR giant have gotten this far. The case centers on Epic's alleged use of its influence over the Carequality data exchange to block Particle's access to patient records and stifle competition in the emerging payer platform market.

Editor's Pick

Top Story Judge Advances Particle Health's Antitrust Lawsuit Against Epic A federal judge has allowed key claims in Particle Health's antitrust lawsuit against Epic to move forward, marking the first time such allegations against the EHR giant have gotten this far. The case centers on Epic's alleged use of its influence over the Carequality data exchange to block Particle's access to patient records and stifle competition in the emerging payer platform market. Sponsored Discover how Mayo Clinic Platform_Solutions Studio can accelerate the commercialization of your digital health solution. Presented by Mayo Clinic Platform_Solutions Studio Whether you're ready to build, validate, or deploy your AI solution into clinical workflows, Solutions Studio offers comprehensive technical and business support tailored to your needs. Learn more. Hurry only 1 Week Away: Grab Your Ticket for INVEST Digital Health Now! We're just one week away until INVEST Digital Health, and there's still time to be part of the experience. This is the moment to get up close with industry leaders, sit in on thought-provoking panels, and build powerful connections that only happen face-to-face. Register Now

Featured News

Takeda Is Waking Up the Narcolepsy Market With First-in-Class Drug, But Alkermes Is on Its Heels Takeda Pharmaceutical's oveporexton is designed to treat the root cause of narcolepsy. Statistically significant Phase 3 results for the twice daily pill were presented Monday during the World Sleep 2025 Congress in Singapore. WeightWatchers Introduces New Menopause Program WeightWatchers' new menopause program provides support from menopause-trained clinicians, along with workshops, fitness guidance and access to prescriptions when needed. Summit Lung Cancer Drug Falls Short on Key Survival Goal in Global Study, Putting FDA Approval in Doubt Despite achieving statistically signficant improvement in progression-free survival in North American and European patients, Summit's drug ivonescimab fell short of the other Phase 3 goal measuring overall survival. It's the first Phase 3 readout for an emerging class of bispecific antibodies that treat cancer by blocking two targets, PD-1 and VEGF. Why Hormone Health Should Be A Standard Part Of Men's Healthcare Testosterone deficiency deserves the same attention we give to any other age-related health concern. Providers can play a big role by starting the conversation when a patient brings up things like low energy, mood changes or reduced sex drive. SOAR Act Would Help Individuals Relying on Oxygen Thrive The bill clarifies very specific patient protections and codifies a Patient's Bill of Rights, all of which would ensure that individuals receiving supplemental oxygen in the home – and their suppliers – understand requirements around equipment, communications, and care options.

Video   Healthcare costs on the rise Employers expect healthcare costs to rise by a median of 9% in 2026, according to a survey by the Business Group on Health. Pharmacy expenses are a key factor.

Sponsored The Top-Rated Suppliers of Lu-177 for Cancer Research Presented by SHINE Technologies With carrier-added and noncarrier-added versions available, the right supplier can make the difference between a program that stalls and one that successfully reaches patients. Learn More.

Resources

MedCity FemFwd: Designing Healthcare Spaces for Women In this episode, we're joined by Abbie Clary, executive director of Health for All for CannonDesign, an architecture design company. She discusses why healthcare traditionally hasn't been built around women, and what needs to change. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe